A detailed history of Omers Administration Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Omers Administration Corp holds 14,955 shares of VRTX stock, worth $6.14 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
14,955
Previous 14,555 2.75%
Holding current value
$6.14 Million
Previous $6.82 Million 1.95%
% of portfolio
0.07%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$460.0 - $505.78 $184,000 - $202,312
400 Added 2.75%
14,955 $6.96 Million
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $5.72 Million - $7.07 Million
14,555 New
14,555 $6.82 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.